EP1950227A1 — HYDROXYPROPYL-SULFOBUTYL-ß-CYCLODEXTRIN, THE PREPARATION METHOD,THE ANALYTICAL METHOD AND THE PHARMACUTICAL APPLICATION THEREOF
Assigned to Hainan Hdeton Science and Technology Co Ltd · Expires 2008-07-30 · 18y expired
What this patent protects
Hydroxypropyl-sulfobutyl-β-cyclodextrin, the preparation method, analytical method, and the pharmaceutical application thereof The hydroxypropyl-sulfobutyl-β-cyclodextrin is a derivative of cyclodextrin which is substituted by a hydroxypropyl group and a sulfobutyl group: n-(2,3,…
USPTO Abstract
Hydroxypropyl-sulfobutyl-β-cyclodextrin, the preparation method, analytical method, and the pharmaceutical application thereof The hydroxypropyl-sulfobutyl-β-cyclodextrin is a derivative of cyclodextrin which is substituted by a hydroxypropyl group and a sulfobutyl group: n-(2,3,6-O-2-hydroxypropyl)-m-(2,3,6-O-sulfobutyl)-β-cyclodextrin. The number of substituent groups per mole cyclodextrin is n hydroxypropyl groups and m sulfobutyl groups. "n" represents the average substituent degree of hydroxypropyl groups; "m" represents the average substituent degree of sulfobutyl groups; "n+m=z" is the gross average substituent degree, in which n is a random integer chosen from 1, 2, 3, 4, 5, 6, 7, 8, 9; m is a random integer chosen from 1, 2, 3, 4, 5 , 6, 7, 8, 9; and the gross average substituent degree z is a random integer chosen from 2, 3, 4, 5, 6, 7, 8, 9, 10. The present invention shows low hemolysis and low toxicity.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.